Advanced MTAP-null Solid Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced MTAP-null Solid Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 1/2

NCT05975073

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphory…

The main aims of this study are to evaluate the safety and tolerability, and to determine the maximum tolerated dose (MTD) or the recommended combination dose o…

United States53 participantsStarted 2023-08-01

Treatment: Anvumetostat, IDE397

Active — Not RecruitingPhase 1/2

NCT05094336

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

The primary objective of Parts 1 and 2 of this study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose (MTD) or recommended p…

United States329 participantsStarted 2022-02-01

Treatment: Anvumetostat, Docetaxel